Some of Wall Street’s biggest companies have been in the vanguard of those pulling employees back into the office as concerns about the pandemic have begun fading.
Prescriptions for Mounjaro have grown rapidly since it was approved in the U.S. in May, and a shortage in a competing drug may drive more patients to Lilly’s medicine.
Creating resilient and agile supply chains requires leveragING economies of scale when working with suppliers while minimizing risk, disruptions and shortages
Italy’s Guardia di Finanza is alleging that Pfizer’s unit, Pfizer Italia Srl, transferred excess capital to affiliates in the U.S. and the Netherlands to avoid taxes on profits
The oral drug, nilotinib, is used to treat chronic myeloid leukemia, and may be made in Egypt, Guatemala, Indonesia, Morocco, Pakistan, the Philippines and Tunisia.
The platform-integrated product eliminates the use of multiple tools, systems and processes and provides users with complete chain of custody tracking.
The deal with Chinese state-owned drug-maker Sinopharm to import and market its antiviral molnupiravir in China is a sign the country is considering more COVID-19 medicines from overseas developers.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.